The SMIF is a reliable reconstructive option for salvage TORS-patients. It is readily available without microvascular expertise, provides healthy vascularized tissue that is outside the at-risk nodal basin, and results in excellent functional outcomes.
No takes yet. Share an insight, caveat, or question.
Groot et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: